Matija Horaček
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matija Horaček has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Ivica Horvatić
Department of Nephrology and Dialysis Dubrava University Hospital Zagreb Croatia
3 shared publications - Petar Šenjug
Department of Pathology, School of Medicine University of Zagreb Zagreb Croatia
3 shared publications - Ante Plećaš
Department of Anatomy, Histology and Embryology, Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia
2 shared publications - Aoife Murray
Faculty of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK
2 shared publications - Danica Galešić Ljubanović
Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia
2 shared publications - Danica Galešić Ljubanović
Faculty of Pharmacy and Biochemistry, University of Zagreb Zagreb Croatia
2 shared publications
Latest Publications
- 3 November 2026
- Published by Wiley in Nephrology
- Vol. 31 (11)
C4d May Predict Treatment Failure and Disease Progression in Primary Focal Segmental Glomerulosclerosis
Aim: To investigate the prognostic significance of C4d, a stable tissue marker of complement activation, in primary focal segmental glomerulosclerosis (pFSGS). Methods: Immunohistochemistry for C4d was performed on paraffin‐embedded tissue in patients with pFSGS and only non‐globally sclerosed glomeruli were evaluated for C4d. Based on the ratio of C4d‐positive glomeruli/total number of glomeruli and number of C4d‐positive non‐sclerotic glomeruli and total number of non‐sclerotic glomeruli, patients were stratified into two subgroups: < 50% or ≥ 50% of C4d‐positive glomeruli. Association of C4d with disease progression (composite of kidney failure and > 50% reduction in baseline eGFR), renal survival and treatment failure was analysed. Results: A total of 58 patients were included. Patients with ≥ 50% of C4d‐positive glomeruli had worse renal survival ( p = 0.005) and higher rate of treatment failure ( p = 0.002) and disease progression ( p = 0.025). Patients with ≥ 50% of C4d‐positive non‐sclerotic glomeruli had worse renal survival ( p = 0.034) and higher rate of treatment failure ( p = 0.009) and disease progression ( p = 0.046). C4d, either in all glomeruli (OR = 7.88, p = 0.013) or non‐sclerotic glomeruli (OR = 4.97, p = 0.021), was independently associated with treatment failure. C4d deposits in ≥ 50% of all glomeruli and nonsclerotic glomeruli only were independently associated with progression to composite outcome (HR = 5.89, p = 0.011) and (HR = 3.93, p = 0.031), respectively, together with percentage of interstitial fibrosis and tubular atrophy. Conclusion: C4d seems to be independently associated with treatment failure and disease progression in pFSGS. Beyond the influence on risk stratification in pFSGS, this study may prompt trials with complement interfering agents in pFSGS.
- 3 November 2026
- Published by Wiley in Nephrology
- Vol. 31 (11)
C4d May Predict Treatment Failure and Disease Progression in Primary Focal Segmental Glomerulosclerosis
Aim: To investigate the prognostic significance of C4d, a stable tissue marker of complement activation, in primary focal segmental glomerulosclerosis (pFSGS). Methods: Immunohistochemistry for C4d was performed on paraffin‐embedded tissue in patients with pFSGS and only non‐globally sclerosed glomeruli were evaluated for C4d. Based on the ratio of C4d‐positive glomeruli/total number of glomeruli and number of C4d‐positive non‐sclerotic glomeruli and total number of non‐sclerotic glomeruli, patients were stratified into two subgroups: < 50% or ≥ 50% of C4d‐positive glomeruli. Association of C4d with disease progression (composite of kidney failure and > 50% reduction in baseline eGFR), renal survival and treatment failure was analysed. Results: A total of 58 patients were included. Patients with ≥ 50% of C4d‐positive glomeruli had worse renal survival ( p = 0.005) and higher rate of treatment failure ( p = 0.002) and disease progression ( p = 0.025). Patients with ≥ 50% of C4d‐positive non‐sclerotic glomeruli had worse renal survival ( p = 0.034) and higher rate of treatment failure ( p = 0.009) and disease progression ( p = 0.046). C4d, either in all glomeruli (OR = 7.88, p = 0.013) or non‐sclerotic glomeruli (OR = 4.97, p = 0.021), was independently associated with treatment failure. C4d deposits in ≥ 50% of all glomeruli and nonsclerotic glomeruli only were independently associated with progression to composite outcome (HR = 5.89, p = 0.011) and (HR = 3.93, p = 0.031), respectively, together with percentage of interstitial fibrosis and tubular atrophy. Conclusion: C4d seems to be independently associated with treatment failure and disease progression in pFSGS. Beyond the influence on risk stratification in pFSGS, this study may prompt trials with complement interfering agents in pFSGS.
- Open Access
- 10 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abnormal neuronal and synaptic morphology in Down syndrome brains reproduces in human isogenic cellular models
Down syndrome (DS) is the most common autosomal aneuploidy compatible with postnatal survival and is caused by full or partial trisomy of chromosome 21. In this study, human isogenic induced pluripotent stem cells (iPSCs) were differentiated into 2D neurons and cortico-striatal assembloids (hCSAs). Abnormal neuronal morphology was observed: trisomic (T21) neurons formed aggregates of cell bodies interconnected with thick neurite bundles radiating outwards, connected and overlapped with other neurons in between the bundles while disomic (D21) neurons were evenly distributed across the surface and formed strong neuronal networks. Detailed analysis revealed significantly shorter neurites with larger diameter, fewer branches, and fewer terminal points in T21 neurons compared to D21 neurons in both 2D cultures and hCSAs. We observed similar phenotypes in foetal and postnatal human brain tissue. Furthermore, we observed abnormal mitochondrial morphology with an excess of some mitochondrial proteins (AIF, TOMM20), abnormal synaptic morphology and significantly lower expression of both presynaptic and postsynaptic markers (SYN-1, PSD95 and GEPH) throughout in vitro differentiation of T21 neurons. Finally, our data showed that T21 spheroids were significantly smaller throughout in vitro differentiation compared to D21 spheroids. T21 spheroids also exhibited significantly higher expression of neural stem cells (SOX2), significantly lower expression of proliferating cells (Ki67) and significantly higher expression of apoptotic cells (CCaspase-3). Overall, our study demonstrates that T21 leads to abnormal neuronal morphology in both 2D neurons and hCSAs, consistent with observations in the human brain.
- 10 June 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessAbnormal neuronal and synaptic morphology in Down syndrome brains reproduces in human isogenic cellular models
Down syndrome (DS) is the most common autosomal aneuploidy compatible with postnatal survival and is caused by full or partial trisomy of chromosome 21. In this study, human isogenic induced pluripotent stem cells (iPSCs) were differentiated into 2D neurons and cortico-striatal assembloids (hCSAs). Abnormal neuronal morphology was observed: trisomic (T21) neurons formed aggregates of cell bodies interconnected with thick neurite bundles radiating outwards, connected and overlapped with other neurons in between the bundles while disomic (D21) neurons were evenly distributed across the surface and formed strong neuronal networks. Detailed analysis revealed significantly shorter neurites with larger diameter, fewer branches, and fewer terminal points in T21 neurons compared to D21 neurons in both 2D cultures and hCSAs. We observed similar phenotypes in foetal and postnatal human brain tissue. Furthermore, we observed abnormal mitochondrial morphology with an excess of some mitochondrial proteins (AIF, TOMM20), abnormal synaptic morphology and significantly lower expression of both presynaptic and postsynaptic markers (SYN-1, PSD95 and GEPH) throughout in vitro differentiation of T21 neurons. Finally, our data showed that T21 spheroids were significantly smaller throughout in vitro differentiation compared to D21 spheroids. T21 spheroids also exhibited significantly higher expression of neural stem cells (SOX2), significantly lower expression of proliferating cells (Ki67) and significantly higher expression of apoptotic cells (CCaspase-3). Overall, our study demonstrates that T21 leads to abnormal neuronal morphology in both 2D neurons and hCSAs, consistent with observations in the human brain.
- Open Access
Abnormal neuronal and synaptic morphology in Down syndrome brains reproduces in human isogenic cellular models
Down syndrome (DS) is the most common autosomal aneuploidy compatible with postnatal survival and is caused by full or partial trisomy of chromosome 21. In this study, human isogenic induced pluripotent stem cells (iPSCs) were differentiated into 2D neurons and cortico-striatal assembloids (hCSAs). Abnormal neuronal morphology was observed: trisomic (T21) neurons formed aggregates of cell bodies interconnected with thick neurite bundles radiating outwards, connected and overlapped with other neurons in between the bundles while disomic (D21) neurons were evenly distributed across the surface and formed strong neuronal networks. Detailed analysis revealed significantly shorter neurites with larger diameter, fewer branches, and fewer terminal points in T21 neurons compared to D21 neurons in both 2D cultures and hCSAs. We observed similar phenotypes in foetal and postnatal human brain tissue. Furthermore, we observed abnormal mitochondrial morphology with an excess of some mitochondrial proteins (AIF, TOMM20), abnormal synaptic morphology and significantly lower expression of both presynaptic and postsynaptic markers (SYN-1, PSD95 and GEPH) throughout in vitro differentiation of T21 neurons. Finally, our data showed that T21 spheroids were significantly smaller throughout in vitro differentiation compared to D21 spheroids. T21 spheroids also exhibited significantly higher expression of neural stem cells (SOX2), significantly lower expression of proliferating cells (Ki67) and significantly higher expression of apoptotic cells (CCaspase-3). Overall, our study demonstrates that T21 leads to abnormal neuronal morphology in both 2D neurons and hCSAs, consistent with observations in the human brain.
Open AccessAbnormal neuronal and synaptic morphology in Down syndrome brains reproduces in human isogenic cellular models
Down syndrome (DS) is the most common autosomal aneuploidy compatible with postnatal survival and is caused by full or partial trisomy of chromosome 21. In this study, human isogenic induced pluripotent stem cells (iPSCs) were differentiated into 2D neurons and cortico-striatal assembloids (hCSAs). Abnormal neuronal morphology was observed: trisomic (T21) neurons formed aggregates of cell bodies interconnected with thick neurite bundles radiating outwards, connected and overlapped with other neurons in between the bundles while disomic (D21) neurons were evenly distributed across the surface and formed strong neuronal networks. Detailed analysis revealed significantly shorter neurites with larger diameter, fewer branches, and fewer terminal points in T21 neurons compared to D21 neurons in both 2D cultures and hCSAs. We observed similar phenotypes in foetal and postnatal human brain tissue. Furthermore, we observed abnormal mitochondrial morphology with an excess of some mitochondrial proteins (AIF, TOMM20), abnormal synaptic morphology and significantly lower expression of both presynaptic and postsynaptic markers (SYN-1, PSD95 and GEPH) throughout in vitro differentiation of T21 neurons. Finally, our data showed that T21 spheroids were significantly smaller throughout in vitro differentiation compared to D21 spheroids. T21 spheroids also exhibited significantly higher expression of neural stem cells (SOX2), significantly lower expression of proliferating cells (Ki67) and significantly higher expression of apoptotic cells (CCaspase-3). Overall, our study demonstrates that T21 leads to abnormal neuronal morphology in both 2D neurons and hCSAs, consistent with observations in the human brain.
- Open Access
- 9 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5338
C4d Is an Independent Predictor of the Kidney Failure in Primary IgA Nephropathy
Background: C4d deposits are present in a substantial proportion of patients with IgA nephropathy (IgAN), indicating the activation of the lectin pathway (LP) of the complement system. It seems that patients with activated LP have worse renal prognosis. The aim of this study was to investigate the prevalence and prognostic significance of C4d in our cohort of patients with primary IgA nephropathy (pIgAN). Methods: Patients with pIgAN were recruited from a hospital register of kidney biopsies of the Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb. Additional immunohistochemistry staining for C4d was performed on paraffin-embedded kidney tissue, and patients were stratified into being C4d positive or C4d negative. The clinical and histologic features of patients were analyzed and compared regarding C4d positivity. The primary outcome was defined as kidney failure (KF), and predictor variables of KF and renal survival were analyzed. Results: Of a total of 95 patients with pIgAN included in the study, C4d was present in 43 (45.3%). C4d-positive patients had a higher value of systolic (p = 0.039) and diastolic (p = 0.006) blood pressure at diagnosis as well as higher 24 h proteinuria (p = 0.018), serum urate (p = 0.033), and lower eGFR (p < 0.001). C4d-positive patients had worse renal survival (p < 0.001), higher rates of disease progression to KF (p < 0.001), and higher proteinuria (p < 0.001) and lower eGFR (p < 0.001) at the last follow-up. Glomerular C4d was an independent predictor of disease progression to KF (HR = 5.87 [0.95 CI 1.06–32.44], p = 0.032). Conclusions: C4d is an independent predictor of disease progression in patients with pIgAN. C4d may be used as an additional marker of progressive disease course in IgAN. The therapeutic implications of C4d status in IgAN, particularly in terms of complement inhibitors application, are not yet known.
- 9 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5338
Open AccessC4d Is an Independent Predictor of the Kidney Failure in Primary IgA Nephropathy
Background: C4d deposits are present in a substantial proportion of patients with IgA nephropathy (IgAN), indicating the activation of the lectin pathway (LP) of the complement system. It seems that patients with activated LP have worse renal prognosis. The aim of this study was to investigate the prevalence and prognostic significance of C4d in our cohort of patients with primary IgA nephropathy (pIgAN). Methods: Patients with pIgAN were recruited from a hospital register of kidney biopsies of the Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb. Additional immunohistochemistry staining for C4d was performed on paraffin-embedded kidney tissue, and patients were stratified into being C4d positive or C4d negative. The clinical and histologic features of patients were analyzed and compared regarding C4d positivity. The primary outcome was defined as kidney failure (KF), and predictor variables of KF and renal survival were analyzed. Results: Of a total of 95 patients with pIgAN included in the study, C4d was present in 43 (45.3%). C4d-positive patients had a higher value of systolic (p = 0.039) and diastolic (p = 0.006) blood pressure at diagnosis as well as higher 24 h proteinuria (p = 0.018), serum urate (p = 0.033), and lower eGFR (p < 0.001). C4d-positive patients had worse renal survival (p < 0.001), higher rates of disease progression to KF (p < 0.001), and higher proteinuria (p < 0.001) and lower eGFR (p < 0.001) at the last follow-up. Glomerular C4d was an independent predictor of disease progression to KF (HR = 5.87 [0.95 CI 1.06–32.44], p = 0.032). Conclusions: C4d is an independent predictor of disease progression in patients with pIgAN. C4d may be used as an additional marker of progressive disease course in IgAN. The therapeutic implications of C4d status in IgAN, particularly in terms of complement inhibitors application, are not yet known.
- Open Access
- 6 January 2023
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 23 (1) , 89-100
Clinical and histopathological characteristics of COL4A3 c.2881+1G>A variant causing Alport spectrum disorders in Croatian population
Alport syndrome (AS) and thin basement membrane nephropathy (TBMN) are part of the spectrum of kidney disorders caused by pathogenic variants in α3, α4, or α5 chains of the collagen type IV, the major structural component of the glomerular basement membrane (GBM). Using targeted next-generation sequencing (NGS), 34 AS/TBMN patients (58.8% male) from 12 unrelated families were found positive for heterozygous c.2881+1G>A variant of the COL4A3gene, that is considered disease-causing. All patients were from the continental or island part of Croatia. Clinical, laboratory, and histopathological data collected from the medical records were analyzed and compared to understand the clinical course and prognosis of the affected patients. At the time of biopsy or first clinical evaluation, the mean age was 31 years (median: 35 years; range: 1 – 72 years). Hematuria was present in 33 patients (97.1%) and 19 (55.9%) patients had proteinuria. There were 6 (17.6%) patients with hearing loss, 4 (11.8%) with ocular lesions, and 11 (32.4%) with hypertension. Twenty-three (67.6%) patients had proteinuria at follow-up, and 5 (14.7%) patients with the median age of 48 years (range: 27-55) progressed to kidney failure, started dialysis, or underwent kidney transplantation. Of the 13 patients who underwent kidney biopsy, 4 (30.8%) developed focal segmental glomerulosclerosis (FSGS), and 8 (66.7%) showed lamellation of the GBM, including all patients with FSGS. It is essential to conduct a detailed analysis of each collagen type IV genetic variant to optimize the prognosis and therapeutic approach for affected patients.
- 6 January 2023
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 23 (1) , 89-100
Open AccessClinical and histopathological characteristics of COL4A3 c.2881+1G>A variant causing Alport spectrum disorders in Croatian population
Alport syndrome (AS) and thin basement membrane nephropathy (TBMN) are part of the spectrum of kidney disorders caused by pathogenic variants in α3, α4, or α5 chains of the collagen type IV, the major structural component of the glomerular basement membrane (GBM). Using targeted next-generation sequencing (NGS), 34 AS/TBMN patients (58.8% male) from 12 unrelated families were found positive for heterozygous c.2881+1G>A variant of the COL4A3gene, that is considered disease-causing. All patients were from the continental or island part of Croatia. Clinical, laboratory, and histopathological data collected from the medical records were analyzed and compared to understand the clinical course and prognosis of the affected patients. At the time of biopsy or first clinical evaluation, the mean age was 31 years (median: 35 years; range: 1 – 72 years). Hematuria was present in 33 patients (97.1%) and 19 (55.9%) patients had proteinuria. There were 6 (17.6%) patients with hearing loss, 4 (11.8%) with ocular lesions, and 11 (32.4%) with hypertension. Twenty-three (67.6%) patients had proteinuria at follow-up, and 5 (14.7%) patients with the median age of 48 years (range: 27-55) progressed to kidney failure, started dialysis, or underwent kidney transplantation. Of the 13 patients who underwent kidney biopsy, 4 (30.8%) developed focal segmental glomerulosclerosis (FSGS), and 8 (66.7%) showed lamellation of the GBM, including all patients with FSGS. It is essential to conduct a detailed analysis of each collagen type IV genetic variant to optimize the prognosis and therapeutic approach for affected patients.
- Open Access
- 30 August 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (9) , 1415
Resistant and Relapsing Collapsing Glomerulopathy Successfully Treated with Rituximab—A Case Report
Collapsing glomerulopathy (CG) or collapsing focal segmental glomerulosclerosis (cFSGS) is an aggressive disease with a high tendency of progression to end-stage renal disease due to common resistance to conventional immunosuppressants. Rituximab (RTX), a monoclonal antibody against CD20 B cells, showed some benefit in the treatment of CG. We are reporting about female patients with an idiopathic form of CG presenting with nephrotic syndrome (NS) and renal insufficiency resistant to several immunosuppressive agents such as steroids (ST), calcineurin inhibitors (CNI), and cyclophosphamide (CYC). This multidrug-resistant disease responded to RTX with complete remission. Forty-four months after initial RTX administration, a relapse of CG with severe NS and acute renal insufficiency occurred. Repeated application of RTX led to complete remission again. To the best of our knowledge, we are reporting the first case of the relapsing multidrug-resistant form of CG, which responded to RTX. Current data about the treatment of CG with RTX is lacking and is based on rare case reports and small case series. Thus, our report can contribute to determining the role of RTX in the treatment of CG.
- 30 August 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (9) , 1415
Open AccessResistant and Relapsing Collapsing Glomerulopathy Successfully Treated with Rituximab—A Case Report
Collapsing glomerulopathy (CG) or collapsing focal segmental glomerulosclerosis (cFSGS) is an aggressive disease with a high tendency of progression to end-stage renal disease due to common resistance to conventional immunosuppressants. Rituximab (RTX), a monoclonal antibody against CD20 B cells, showed some benefit in the treatment of CG. We are reporting about female patients with an idiopathic form of CG presenting with nephrotic syndrome (NS) and renal insufficiency resistant to several immunosuppressive agents such as steroids (ST), calcineurin inhibitors (CNI), and cyclophosphamide (CYC). This multidrug-resistant disease responded to RTX with complete remission. Forty-four months after initial RTX administration, a relapse of CG with severe NS and acute renal insufficiency occurred. Repeated application of RTX led to complete remission again. To the best of our knowledge, we are reporting the first case of the relapsing multidrug-resistant form of CG, which responded to RTX. Current data about the treatment of CG with RTX is lacking and is based on rare case reports and small case series. Thus, our report can contribute to determining the role of RTX in the treatment of CG.